| 基因名 | 疾病 | 靶向药 | 化疗药 | 基因突变 | 临床解释 |
|---|---|---|---|---|---|
| G3BP1 | 0 | 0 | |||
| G3BP2 | 0 | 0 | |||
| G6PC | 0 | 0 | |||
| G6PC3 | 0 | 0 | |||
| GAB2 | 0 | 0 | |||
| GABRA2 | 0 | 0 | |||
| GABRA6 | 0 | 0 | |||
| GABRP | 0 | 0 | |||
| GADD45A | 卵巢癌 | 1 | 1 | ||
| GALNT11 | 0 | 0 | |||
| GALNT12 | 0 | 0 | |||
| GALNT14 | 0 | 0 | |||
| GANC | 0 | 0 | |||
| GAPDH | 0 | 0 | |||
| GAS6 | 口腔鳞状细胞癌 | 多西他赛, | 1 | 2 | |
| GAST | 0 | 0 | |||
| GATA1 | 0 | 0 | |||
| GATA2 | 肺腺癌 | 硼替佐米, | 法舒地尔, | 1 | 1 |
| GATA3 | 0 | 0 | |||
| GATA4 | 0 | 0 | |||
| GATA6 | 0 | 0 | |||
| GDF1 | 0 | 0 | |||
| GDF15 | 0 | 0 | |||
| GEN1 | 0 | 0 | |||
| GFRAL | 0 | 0 | |||
| GGH | 0 | 0 | |||
| GID4 | 0 | 0 | |||
| GIGYF1 | 0 | 0 | |||
| GJB2 | 0 | 0 | |||
| GKN2 | 0 | 0 | |||
| GLB1L3 | 0 | 0 | |||
| GLI1 | 细胞周瘤 | 1 | 1 | ||
| GLI2 | 0 | 0 | |||
| GLI3 | 0 | 0 | |||
| GMEB1 | 0 | 0 | |||
| GMPS | 0 | 0 | |||
| GNA11 | 葡萄膜黑色素瘤 | AEB071,卡博替尼,JQ1,PD0325901,司美替尼,曲美替尼, | 2 | 5 | |
| GNA12 | 0 | 0 | |||
| GNA13 | 0 | 0 | |||
| GNAQ | 皮肤黑色素瘤,葡萄膜黑色素瘤 | AEB071,Refametinib,卡博替尼,JQ1,PD0325901,PLX4720,司美替尼,曲美替尼,维莫非尼, | 3 | 8 | |
| GNAS | 膀胱尿路上皮癌,乳腺癌,慢性淋巴细胞白血病,透明细胞肾细胞癌,结直肠癌,食管癌,滤泡性甲状腺癌,肝内胆管癌,非小细胞肺癌,黑色素瘤,腹膜假黏液瘤 | 西妥昔单抗,厄洛替尼,吉非替尼,Radioactive Iodine,维莫非尼, | 氟尿嘧啶,顺铂,伊立替康, | 4 | 12 |
| GNG2 | 0 | 0 | |||
| GNRHR | 0 | 0 | |||
| GOPC | 0 | 0 | |||
| GPAT3 | 0 | 0 | |||
| GPC3 | 0 | 0 | |||
| GPM6A | 0 | 0 | |||
| GPR101 | 0 | 0 | |||
| GPR124 | 0 | 0 | |||
| GPR158 | 0 | 0 | |||
| GPS2 | 0 | 0 | |||
| GPX1 | 0 | 0 | |||
| GRB2 | 0 | 0 | |||
| GRB7 | 0 | 0 | |||
| GREM1 | 0 | 0 | |||
| GRID1 | 0 | 0 | |||
| GRIK3 | 0 | 0 | |||
| GRIN2A | 0 | 0 | |||
| GRM3 | 0 | 0 | |||
| GRM8 | 0 | 0 | |||
| GSK3B | 0 | 0 | |||
| GSTA1 | 0 | 0 | |||
| GSTM1 | 0 | 0 | |||
| GSTM3 | 0 | 0 | |||
| GSTM4 | 0 | 0 | |||
| GSTM5 | 0 | 0 | |||
| GSTP1 | 结直肠癌,卵巢癌 | FolfoxProtocol, | 卡铂,顺铂,紫杉醇, | 2 | 2 |
| GSTT1 | 0 | 0 | |||
| GUSB | 0 | 0 |
Copyright © 2020 基因医生
京ICP备13051264号-65 
京公网安备
11010802036025号